Hepatocellular carcinoma (HCC) is a global health problem and responsible for up to
500.000 deaths annually. It usually occurs secondary to infections with hepatitis B or C …

As the fifth most common cancer in men and the eighth most common cancer in women,
hepatocellular carcinoma (HCC) is the leading cause of cancer‐related deaths worldwide …

Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and occurs mainly
in patients with liver cirrhosis. The mammalian target of rapamycin (mTOR) signaling …

Mechanistic target of rapamycin (mTOR) regulates cell growth, metabolism and aging in
response to nutrients, cellular energy stage and growth factors. mTOR is frequently up …

The mechanistic/mammalian target of rapamycin (mTOR) pathway plays a critical role in
cellular metabolism, growth, and proliferation and has been evaluated as a target for therapy …

Mammalian target of rapamycin (mTOR) plays a central role in the regulation of cellular
growth, proliferation, and survival via a cytoplasmic serine/threonine kinase. mTOR also …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death
worldwide. It is associated with a poor prognosis and has limited treatment options …

mTOR is a central regulator of cell growth and angiogenesis. The mTOR pathway is
activated in 40–50% of patients with hepatocellular cancer (HCC). In different models (ie …

The mortality of hepatocellular carcinoma (HCC) is distributed unevenly worldwide. One of
the major causes is hepatitis B or hepatitis C virus infection and the development and …

Introduction: Hepatocellular carcinoma (HCC) is a major health problem worldwide. Several
molecular pathways involved in HCC growth and progression have recently been identified …